• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

    2/10/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary
    Get the next $WW alert in real time by email

    NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability training.

    As weight health enters a new era driven by GLP-1 medications and growing awareness of the role lean muscle plays in metabolism, Weight Watchers continues to innovate its science-backed approach to deliver even stronger outcomes for members. Building and preserving muscle plays an important role in long-term health, especially for women in midlife and members using GLP-1 medications.

    To meet these evolving needs, Weight Watchers is further expanding its integrated approach by deepening its strength-forward movement offerings through PVOLVE's clinically validated method to support members throughout their weight health journey and promote overall longevity.

    Starting today, Weight Watchers members will gain access to exclusive PVOLVE classes suitable for all fitness levels and life stages through the WeightWatchers Core, Core+, Med+, GLP-1 Success and Menopause programs. Members will also be able to upgrade to PVOLVE's full on-demand library through Weight Watchers and purchase a curated starter kit featuring PVOLVE's best-selling unique resistance equipment.

    For members using GLP-1 medications, strength training plays a critical role in supporting lean muscle and long-term success. The Weight Watchers Med+ Program, which includes their GLP-1 Success Program combines board-certified clinicians, behavioral science, personalized nutrition, strength-building plans, and expert coaching and community support to help manage side effects and deliver better outcomes than medication alone.

    Data shows the positive impact of this integrated approach. At one month, regularly engaged Weight Watchers Med+ members lost 61.3% more body weight than those who took medicine alone; and at twelve months, 29.1% more.

    Women lose 3-5% of muscle mass per decade, starting at age 30, but PVOLVE's workouts have been shown to help partially offset this decline. In a 12-week PVOLVE program, participants experienced significant increases in lean muscle mass and improved lower body strength by 19%.

    By pairing Weight Watchers' holistic approach to nutrition, behavior change support, and medical care with PVOLVE's fitness method, members receive a more personalized and comprehensive approach to weight health.

    "As the definition of weight health evolves, so does our approach," said Julie Rice, Chief Experience Officer of Weight Watchers. "This partnership with PVOLVE builds on our foundation by bringing more strength-forward movement into our ecosystem alongside nutrition, behavior change, coaching, and medical care - so our members can achieve more sustainable, long-term results."

    "Movement should empower you, not exhaust you," said Rachel Katzman, Founder of PVOLVE. "PVOLVE was created to help people feel strong, capable, and confident in their bodies through every stage of life, and we saw a natural partnership with Weight Watchers in that shared vision. For more than six decades, they've supported millions of people with a science-backed, comprehensive approach to health, and together we're bringing movement, nutrition, medical care and coaching together in a way that truly supports real, lasting change and longevity."

    What Members Receive Through Weight Watchers + PVOLVE Partnership:

    As part of the collaboration, all Weight Watchers members will gain access to exclusive benefits from PVOLVE, including:

    • Weight Watchers + PVOLVE Streaming Membership: Immediate access to select custom PVOLVE workouts through the Weight Watchers app – designed for all fitness levels and life stages, with specialized series for women in perimenopause and menopause, and a dedicated GLP-1 strength series.
    • Expanded PVOLVE streaming experience: The opportunity to unlock the full PVOLVE library of 1,700+ on-demand classes through the Weight Watchers app at a special reduced member rate.
    • Weight Watchers + PVOLVE Starter Kit: A curated kit featuring PVOLVE's best-selling essentials, which include – Gliders, Floor Gloves, Heavy Ankle Band, P.ball, and P.band, also at a reduced member rate.



    As weight health solutions become increasingly fragmented, Weight Watchers is setting the industry standard by delivering a fully integrated experience that unites medical care, nutrition, behavior change, and movement in one connected platform. The partnership with PVOLVE builds on this foundation to further recognize strength, mobility, and muscle preservation as essential contributing pillars of lasting weight health.

    ABOUT WEIGHT WATCHERS

    Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business' full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.

    ABOUT PVOLVE

    PVOLVE is the first clinically-proven movement longevity company- built on a method that uniquely combines the three pillars of longevity training: strength, mobility, and stability. Using patented resistance equipment and functional movement patterns, PVOLVE sculpts and tones the body while helping members move better, longer. Founded by Rachel Katzman in 2017, the PVOLVE Method is backed by a Clinical Advisory Board of expert physicians and highly credentialed trainers with expertise in human physiology and biomechanics. In June 2023, world-renowned actress Jennifer Aniston officially partnered with PVOLVE after experiencing transformative results, calling the method "a game changer" for how she felt and looked. PVOLVE has a hybrid fitness model, offering more than 1,700 on-demand workouts, a two-way live virtual studio, and targeted series across web and mobile apps. The brand has over 30 studio locations open across North America, with more than 50 additional studios in development. Learn more at pvolve.com and pvolvefranchise.com.

    For media inquiries, please contact:

    Lizzy Levitan 

    [email protected]

    For investor inquiries, please contact:

    John Mills or Anna Kate Heller

    [email protected]



    Primary Logo

    Get the next $WW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WW

    DatePrice TargetRatingAnalyst
    9/15/2025Market Perform
    CJS Securities
    7/26/2024$6.50 → $1.25Overweight → Equal-Weight
    Morgan Stanley
    1/3/2024$8.00Underweight
    Barclays
    12/20/2023$14.00Buy
    Guggenheim
    9/27/2023$4.00 → $10.00Sell → Hold
    Craig Hallum
    7/26/2023$5.00 → $13.00Equal-Weight → Overweight
    Morgan Stanley
    4/11/2023$3.80 → $13.00Neutral → Buy
    Goldman
    3/8/2023$4.00Hold → Sell
    Craig Hallum
    More analyst ratings

    $WW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

    NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability training. As weight health enters a new era driven by GLP-1 medications and growing awareness of the role lean muscle plays in metabolism, Weight Watchers continues to innovate its science-backed approach to deliver even stronger outcomes for members. Building and preserving muscle plays an important role in long-term health, especially for women in midlife and members using GL

    2/10/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers to Participate in Upcoming Investor Conferences

    NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that the Company will be participating in the following investor conferences in January: January 12-13, 2026: ICR Conference in Orlando, FL. The Company will host meetings with investors throughout the event.January 14, 2026: CJS Securities 26th Annual New Ideas for the New Year. The Company will be participating in a virtual fireside chat at 11:00 a.m. ET. The fireside chat will be accessible via live audio webcast on the Company's corporate website, corporate.ww.com, under Events and Presentations. A r

    1/7/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health

    NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced access to Novo Nordisk's newly FDA approved oral formulation of Wegovy® through its integrated GLP-1 platform. The addition of a once-daily Wegovy pill expands access to GLP-1 treatment and reinforces Weight Watchers' leadership in delivering comprehensive care models that help people succeed on medication in real life by pairing medical therapy with evidence-based behavior change and ongoing support. Weight Watchers, through its affiliated Weight Watchers Clinic, is a NovoCare® Recognized Care Provider based on its demonstr

    1/5/26 8:05:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    SEC Filings

    View All

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    12/23/25 4:05:21 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 POS filed by WW International Inc.

    S-8 POS - WW INTERNATIONAL, INC. (0000105319) (Filer)

    11/6/25 4:22:09 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 POS filed by WW International Inc.

    S-8 POS - WW INTERNATIONAL, INC. (0000105319) (Filer)

    11/6/25 4:20:13 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney was granted 1,166 shares, increasing direct ownership by 4% to 31,442 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:12 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Bornstein Julie was granted 1,166 shares, increasing direct ownership by 67% to 2,918 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:10 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Director O'Connor-Brooks Fallon Julia

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:09 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CJS Securities initiated coverage on WW

    CJS Securities initiated coverage of WW with a rating of Market Perform

    9/15/25 10:08:29 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WW downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously

    7/26/24 7:46:12 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Barclays initiated coverage on WW with a new price target

    Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00

    1/3/24 8:36:04 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Kelly Denis F bought $49,897 worth of shares (64,500 units at $0.77), increasing direct ownership by 80% to 145,421 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:13:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Sistani Sima bought $48,555 worth of shares (65,000 units at $0.75), increasing direct ownership by 32% to 267,410 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:06:22 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Financials

    Live finance-specific insights

    View All

    WeightWatchers Schedules Third Quarter 2025 Earnings Conference Call

    NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co

    10/30/25 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Announces Second Quarter 2025 Results

    Successful completion of strategic reorganization, reducing debt by $1.15 billion.In connection with emergence on 6/24/25, fiscal Q2 consists of a "Predecessor" period from 3/30/25 to 6/24/25, and a "Successor" period from 6/25/25 to 6/30/25 Combined End of Period Subscribers1 of 3.2 million; Combined End of Period Clinical Subscribers1 of 127 thousand Combined Revenues1 of $189 million, down 6% vs. prior year; Combined Clinical Revenues1 of $31 million, up 55% vs. prior year Predecessor Net Income1 of $1,191 million and Net Margin1 of 673% were impacted by Reorganization items; Successor Net Income1 of $1 million and Net Margin1 of 10%; Predecessor Adjusted EBITDA1,2 of $61 milli

    8/11/25 7:00:37 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence

    NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") reschedules its earnings release and conference call for the quarterly period ended June 30, 2025, to finalize its Fresh Start Accounting adoption in connection with the emergence from its financial reorganization process on June 24, 2025. The earnings release and call was originally scheduled before the market opened on Tuesday, August 5, 2025. WeightWatchers will now release its second quarter 2025 earnings release before market open on Monday, August 11, 2025, and host a conference call to discuss results the same day at 8:30 a.m. ET. The webcast of the conference c

    8/4/25 5:38:53 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/14/24 6:06:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/8/24 10:40:45 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by WW International Inc.

    SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)

    2/14/24 6:58:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Leadership Updates

    Live Leadership Updates

    View All

    Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme

    NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking programme that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the programme, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman. "Menopause has been a new journey for me—one that's changed how I see a

    9/8/25 8:54:36 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program

    NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking program that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman "Menopause has been a new journey for me—one that's changed how I s

    9/8/25 8:50:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Advances International Growth With Strategic Leadership Appointment

    NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers' business outside of the United States, driving international growth and innovation across the Company's global footprint. With more than two decades of experience scaling consumer, e-commerce, and marketplace businesses worldwide, Bethlen will play a pivotal role in strengthening WeightWatchers' leadership in weight health. "Alejandro's international e

    9/3/25 4:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary